Europe Gene Expression Market Size & Outlook, 2022-2030

The gene expression market in Europe is expected to reach a projected revenue of US$ 4,572.9 million by 2030. A compound annual growth rate of 4.3% is expected of Europe gene expression market from 2023 to 2030.
Revenue, 2022 (US$M)
$3,264.6
Forecast, 2030 (US$M)
$4,572.9
CAGR, 2023 - 2030
4.3%
Report Coverage
Europe

Europe gene expression market highlights

  • The Europe gene expression market generated a revenue of USD 3,264.6 million in 2022.
  • The market is expected to grow at a CAGR of 4.3% from 2023 to 2030.
  • In terms of segment, cdna synthesis & conversion was the largest revenue generating process in 2022.
  • Data Analysis & Interpretation is the most lucrative process segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.


Europe data book summary

Market revenue in 2022USD 3,264.6 million
Market revenue in 2030USD 4,572.9 million
Growth rate4.3% (CAGR from 2022 to 2030)
Largest segmentCdna synthesis & conversion
Fastest growing segmentData Analysis & Interpretation
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSample Collection, Purification, CDNA Synthesis & Conversion, PCR Analysis, Data Analysis & Interpretation
Key market players worldwideCatalent Inc, Qiagen NV, Quest Diagnostics Inc, Roche, Illumina Inc, PerkinElmer, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Agilent Technologies, GE HealthCare Technologies Inc Common Stock, Promega, Luminex, Takara Bio Inc, Danaher Corp


Other key industry trends

  • In terms of revenue, Europe region accounted for 23.4% of the global gene expression market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 5,754.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Gene Expression Market Companies

Name Profile # Employees HQ Website

Europe gene expression market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene expression market will help companies and investors design strategic landscapes.


Cdna synthesis & conversion was the largest segment with a revenue share of 27.26% in 2022. Horizon Databook has segmented the Europe gene expression market based on sample collection, purification, cdna synthesis & conversion, pcr analysis, data analysis & interpretation covering the revenue growth of each sub-segment from 2018 to 2030.


Local presence of key players as well as national & international organizations, such as the European Union (EU) and European Bioinformatics Institute (EBI), has contributed to the region’s substantial share in the market. Extended support is available for advanced research in gene expression analysis in the region.

For instance, Expression Atlas, an open resource offered by EMBL-EBI, provides information regarding protein & gene expression. It supports numerous genomic & gene expression profiling projects conducted by researchers across Europe.

Reasons to subscribe to Europe gene expression market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe gene expression market databook

  • Our clientele includes a mix of gene expression market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe gene expression market, including forecasts for subscribers. This continent databook contains high-level insights into Europe gene expression market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe gene expression analysis market size, by country, 2018-2030 (US$M)

Europe Gene Expression Market Share, 2022 & 2030 (US$M)

Europe gene expression analysis market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more